A simple and effective preparation for the protection of in vitro-derived seedlings from phytopathogens has been developed by a scientific team of NUST MISIS together with colleagues from Voronezh and Tambov. Small doses of copper oxide nanoparticles in its composition work as an immunostimulator of plants. As a result, scientists are planning to obtain a preparation that will increase the amount of harvested planting material. The results of the work have been published in the Nanomaterials international scientific journal.
There are some challenges with the new technology: as nutrient media for phytoclones provide ideal conditions for microbial growth, new plants need to be created and maintained in complete sterility. Antibiotics are increasingly being used to reduce the risk of contamination in plants propagated in vitro.
However, along with the bactericidal effect, antibiotics can also have a toxic effect on plant tissues, inhibit their growth and development. In addition, microorganisms can adapt to biocidal drugs by mutations, which leads to the resistance of phytopathogens. According to Russian scientists, the use of nanoparticles as sterilizing agents could be a safe alternative to antibiotics.
The research team of scientists from NUST MISIS, Voronezh State University of Forestry and Technologies named after G.F. Morozov and Tambov State University named after G. R. Derzhavin aimed to assess the effects of copper oxide nanoparticles on the growth of colonies of spore-forming mold fungi, as well as on the production of stress resistance genes in birch clones in vitro when infected with phytopathogens.
“As we expected, copper oxide nanoparticles had a pronounced antifungal effect on phytopathogens in plant culture, which is consistent with the results of a number of previous studies. As possible mechanisms of this phenomenon, we assume both the diffusion of copper ions, which is an antimicrobial agent, and specific nanotoxic effects, such as the induction of oxidative stress or damage to the cell membrane,” said Olga Zakharova, an expert from the Department of Functional Nanosystems and High-Temperature Materials at NUST MISIS.
Interestingly, according to the developers, the maximum sterility of plants was observed at the lowest concentration of nanoparticles studied. Scientists suggest that the effect is achieved not through the direct destruction of phytopathogenic microorganisms by nanoparticles, but indirectly through the stimulation of immunity of seedlings.
“Nanoparticles in low concentrations can cause moderate stress in plants, one of the reactions to which is a change in their biochemical status. Compounds such as peroxidases and polyphenols, which are part of the system of non-specific protection of plants against phytopathogenic microorganisms, are beginning to be produced. At the same time, an increase in the concentration of nanoparticles increases the ‘nano’ induced stress, and the overall efficiency of plant adaptation to stress begins to decrease, which is ultimately manifested by a reduced number of viable microclones at the maximum concentration of nanoparticles,” Olga Zakharova added.
According to the researchers, the obtained data confirm the prospect of using copper oxide nanoparticles to optimize the technology of plant cultivation in vitro. The next stage of the project is to accurately identify the mechanisms by which nanoparticles affect plants and phytopathogens.
News
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]















